CN113185725B - 一种原位快速制备银纳米粒子/明胶复合水凝胶的方法 - Google Patents
一种原位快速制备银纳米粒子/明胶复合水凝胶的方法 Download PDFInfo
- Publication number
- CN113185725B CN113185725B CN202110410495.5A CN202110410495A CN113185725B CN 113185725 B CN113185725 B CN 113185725B CN 202110410495 A CN202110410495 A CN 202110410495A CN 113185725 B CN113185725 B CN 113185725B
- Authority
- CN
- China
- Prior art keywords
- gelatin
- dopamine
- aqueous solution
- composite hydrogel
- silver nanoparticle
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 108010010803 Gelatin Proteins 0.000 title claims abstract description 229
- 229920000159 gelatin Polymers 0.000 title claims abstract description 229
- 235000019322 gelatine Nutrition 0.000 title claims abstract description 229
- 235000011852 gelatine desserts Nutrition 0.000 title claims abstract description 229
- 239000008273 gelatin Substances 0.000 title claims abstract description 228
- 239000000017 hydrogel Substances 0.000 title claims abstract description 101
- 239000002131 composite material Substances 0.000 title claims abstract description 84
- 229910052709 silver Inorganic materials 0.000 title claims abstract description 79
- 239000004332 silver Substances 0.000 title claims abstract description 79
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 title claims abstract description 77
- 239000002105 nanoparticle Substances 0.000 title claims abstract description 76
- 238000000034 method Methods 0.000 title claims abstract description 47
- 238000011065 in-situ storage Methods 0.000 title claims abstract description 27
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 claims abstract description 324
- 229960003638 dopamine Drugs 0.000 claims abstract description 162
- 239000007864 aqueous solution Substances 0.000 claims abstract description 85
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 claims abstract description 50
- 239000000243 solution Substances 0.000 claims abstract description 30
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 27
- 229910001961 silver nitrate Inorganic materials 0.000 claims abstract description 25
- 238000003756 stirring Methods 0.000 claims abstract description 25
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical group Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 claims abstract description 21
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 claims abstract description 21
- 238000002360 preparation method Methods 0.000 claims abstract description 16
- 239000007822 coupling agent Substances 0.000 claims abstract description 8
- 238000006243 chemical reaction Methods 0.000 claims abstract description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 18
- 238000000502 dialysis Methods 0.000 claims description 18
- FOIXSVOLVBLSDH-UHFFFAOYSA-N Silver ion Chemical compound [Ag+] FOIXSVOLVBLSDH-UHFFFAOYSA-N 0.000 claims description 17
- 239000000203 mixture Substances 0.000 claims description 9
- 229910052757 nitrogen Inorganic materials 0.000 claims description 9
- 239000002245 particle Substances 0.000 claims description 6
- 238000004108 freeze drying Methods 0.000 claims description 4
- 239000003960 organic solvent Substances 0.000 abstract description 5
- 230000007613 environmental effect Effects 0.000 abstract description 2
- 239000000499 gel Substances 0.000 abstract description 2
- 229940014259 gelatin Drugs 0.000 description 187
- AOJJSUZBOXZQNB-TZSSRYMLSA-N Doxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 0.000 description 10
- 238000001035 drying Methods 0.000 description 7
- 230000008569 process Effects 0.000 description 5
- 239000003431 cross linking reagent Substances 0.000 description 4
- 229960004679 doxorubicin Drugs 0.000 description 4
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 239000003999 initiator Substances 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- -1 silver ions Chemical class 0.000 description 3
- 150000003384 small molecules Chemical class 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- OSSNTDFYBPYIEC-UHFFFAOYSA-N 1-ethenylimidazole Chemical compound C=CN1C=CN=C1 OSSNTDFYBPYIEC-UHFFFAOYSA-N 0.000 description 2
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- 238000004132 cross linking Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 238000010526 radical polymerization reaction Methods 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical class C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 229940009456 adriamycin Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 239000013522 chelant Substances 0.000 description 1
- 229940045110 chitosan Drugs 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000004146 energy storage Methods 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 238000007901 in situ hybridization Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000001000 micrograph Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 239000002086 nanomaterial Substances 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- GGCZERPQGJTIQP-UHFFFAOYSA-N sodium;9,10-dioxoanthracene-2-sulfonic acid Chemical compound [Na+].C1=CC=C2C(=O)C3=CC(S(=O)(=O)O)=CC=C3C(=O)C2=C1 GGCZERPQGJTIQP-UHFFFAOYSA-N 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J3/00—Processes of treating or compounding macromolecular substances
- C08J3/24—Crosslinking, e.g. vulcanising, of macromolecules
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08H—DERIVATIVES OF NATURAL MACROMOLECULAR COMPOUNDS
- C08H1/00—Macromolecular products derived from proteins
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J3/00—Processes of treating or compounding macromolecular substances
- C08J3/02—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques
- C08J3/03—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques in aqueous media
- C08J3/075—Macromolecular gels
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2389/00—Characterised by the use of proteins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K3/00—Use of inorganic substances as compounding ingredients
- C08K3/02—Elements
- C08K3/08—Metals
- C08K2003/0806—Silver
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K2201/00—Specific properties of additives
- C08K2201/011—Nanostructured additives
Landscapes
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Dispersion Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Materials Engineering (AREA)
- Engineering & Computer Science (AREA)
- Colloid Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110410495.5A CN113185725B (zh) | 2021-04-16 | 2021-04-16 | 一种原位快速制备银纳米粒子/明胶复合水凝胶的方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110410495.5A CN113185725B (zh) | 2021-04-16 | 2021-04-16 | 一种原位快速制备银纳米粒子/明胶复合水凝胶的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113185725A CN113185725A (zh) | 2021-07-30 |
CN113185725B true CN113185725B (zh) | 2022-11-11 |
Family
ID=76977182
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110410495.5A Active CN113185725B (zh) | 2021-04-16 | 2021-04-16 | 一种原位快速制备银纳米粒子/明胶复合水凝胶的方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113185725B (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113975462B (zh) * | 2021-11-10 | 2022-12-06 | 中新国际联合研究院 | 一种多巴胺功能化的神经活性水凝胶的制备方法 |
CN114316307B (zh) * | 2021-12-31 | 2023-10-27 | 广东粤港澳大湾区国家纳米科技创新研究院 | 改性水凝胶及其制备方法和应用 |
CN115852590B (zh) * | 2022-09-28 | 2023-10-10 | 青岛德冠超导材料制造有限公司 | 天然抗菌防静电纳米纤维膜及其制备方法和用途 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106977757A (zh) * | 2017-04-27 | 2017-07-25 | 西南大学 | 纳米银功能化的多巴胺‑丝胶复合薄膜的制备方法及其产品和应用 |
CN110117369A (zh) * | 2019-05-16 | 2019-08-13 | 吉林大学 | 一种抗菌粘附的导电水凝胶及其制备方法和应用 |
-
2021
- 2021-04-16 CN CN202110410495.5A patent/CN113185725B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106977757A (zh) * | 2017-04-27 | 2017-07-25 | 西南大学 | 纳米银功能化的多巴胺‑丝胶复合薄膜的制备方法及其产品和应用 |
CN110117369A (zh) * | 2019-05-16 | 2019-08-13 | 吉林大学 | 一种抗菌粘附的导电水凝胶及其制备方法和应用 |
Non-Patent Citations (2)
Title |
---|
Hui Zhang et al.."Multifunctional Injectable Hydrogel Dressings for Effectively Accelerating Wound Healing: Enhancing Biomineralization Strategy".《ADVANCED FUNCTIONAL MATERIALS》.2021,第31卷(第23期),文献号2100093. * |
Phuong Le Thi et al.."Catechol-rich gelatin hydrogels in situ hybridizations with silver nanoparticle for enhanced antibacterial activity".《Materials Science & Engineering C》.2018,第52-60页. * |
Also Published As
Publication number | Publication date |
---|---|
CN113185725A (zh) | 2021-07-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN113185725B (zh) | 一种原位快速制备银纳米粒子/明胶复合水凝胶的方法 | |
Liao et al. | Preparation, properties and drug controlled release of chitin-based hydrogels: An updated review | |
Yeo et al. | Dual-crosslinked, self-healing and thermo-responsive methylcellulose/chitosan oligomer copolymer hydrogels | |
Rogovina et al. | Polysaccharide-based polymer blends: Methods of their production | |
CN101665576B (zh) | 基于环糊精的微凝胶及其制备方法 | |
Yan et al. | Controlled release of curcumin from gelatin hydrogels by the molecular-weight modulation of an oxidized dextran cross-linker | |
CN109796606B (zh) | 一种基于多重动态化学键的自愈合水凝胶及其制备方法 | |
Bazhban et al. | Electrospinning of cyclodextrin functionalized chitosan/PVA nanofibers as a drug delivery system | |
Guo et al. | Biofunctional chitosan–biopolymer composites for biomedical applications | |
CN111471193B (zh) | 一种双醛多糖纳米颗粒交联胶原水凝胶及其制备方法 | |
Haroun et al. | Encapsulation of bovine serum albumin within β-cyclodextrin/gelatin-based polymeric hydrogel for controlled protein drug release | |
Kang et al. | A facile method for preparation of green and antibacterial hydrogel based on chitosan and water-soluble 2, 3-dialdehyde cellulose | |
Hu et al. | Preparation and characterization of composite hydrogel beads based on sodium alginate | |
Maiti et al. | Carboxymethyl xanthan microparticles as a carrier for protein delivery | |
CN111012947B (zh) | 一种可注射和自愈合淀粉基水凝胶及其制备方法和应用 | |
Wang et al. | Biopolymer-based self-healing hydrogels: A short review | |
Ren et al. | Injectable supramolecular hydrogels based on host–guest interactions with cell encapsulation capabilities | |
CN113583257A (zh) | 一种电致黏附水凝胶及其制备方法 | |
Augustine et al. | Crosslinking strategies to develop hydrogels for biomedical applications | |
CN1830420A (zh) | 一种可注射型pH敏感壳聚糖季铵盐水凝胶及其制备方法 | |
Bazghaleh et al. | Preparation and characterization of oxidized pectin/N-succinyl chitosan/graphene oxide hydrogels | |
CN106832342B (zh) | 一种纳米淀粉粒子补强的醛肼交联型可注射pnipam水凝胶的制备方法 | |
CN114891239B (zh) | 一种硼氮内配位硼酸酯水凝胶及其制备方法 | |
WO2019192628A2 (zh) | 壳聚糖巯基化衍生物、壳聚糖水凝胶及其制备方法与应用 | |
JP2001081237A (ja) | 水膨潤性医療用高分子ゲルの製造法及び水膨潤性医療用高分子ゲル |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240204 Address after: Room 1018-15, Building 23, Times Square, Suzhou Industrial Park, Suzhou Area, China (Jiangsu) Pilot Free Trade Zone, Suzhou City, Jiangsu Province, 215000 Patentee after: Suzhou 30 billion Technology Co.,Ltd. Country or region after: China Address before: 314001 Building 2, photovoltaic technology innovation park, 1288 Kanghe Road, Xiuzhou District, Jiaxing City, Zhejiang Province Patentee before: JIAXING University Country or region before: China |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240221 Address after: 225699 Changjiang Road, Gaoyou Economic Development Zone, Yangzhou City, Jiangsu Province Patentee after: JIANGSU OPERA MEDICAL SUPPLIES CO.,LTD. Country or region after: China Address before: Room 1018-15, Building 23, Times Square, Suzhou Industrial Park, Suzhou Area, China (Jiangsu) Pilot Free Trade Zone, Suzhou City, Jiangsu Province, 215000 Patentee before: Suzhou 30 billion Technology Co.,Ltd. Country or region before: China |
|
TR01 | Transfer of patent right |